Category Archives: Patent

MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine

New Delhi, 13 October 2017 – Médecins Sans Frontières/Doctors Without Borders India has filed a petition before the High Court of Delhi to overturn the patent granted on the pneumococcal conjugate vaccine (PCV) to the US pharmaceutical corporation Pfizer. Earlier … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent examination system, Patent Opposition, Uncategorized | Tagged , , | Leave a comment

UACT ASKS CEOS FOR TRANSPARENCY ON CAR T TREATMENTS

Today, UACT submitted letters to the CEOs of three major pharmaceutical companies currently developing chimeric antigen receptor T-cell (CAR T) technologies.  UACT asked the leaders of Novartis, Gilead Sciences, and Juno Therapeutics to address questions regarding research and development (R&D) … Continue reading

Posted in Cancer, Drug prices, Gene Therapy, Patent, R&D, Uncategorized | Leave a comment

Pfizer patent for pneumonia drug could have a deadly impact on public health

India carries the world’s highest burden of pneumonia and accounts for nearly 20% of global infant pneumonia deaths Opinion piece: Leena Menghaney, The Hindustan Times India’s Patent Office has dealt a major setback to hopes for improved access to an … Continue reading

Posted in Indian Patent Law, Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Dangerous pneumonia on the loose, but affordable vaccine to get tough to procure; uproar sparked off; reason will SHOCK you

Source: The Financial Express Access to affordable pneumococcal conjugate vaccine (PCV) will become tougher after the Indian patent office granted a patent to US pharma major Pfizer for its PCV13 product, marketed as Prevnar13. Access to affordable pneumococcal conjugate vaccine … Continue reading

Posted in Indian Patent Office, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

India grants Pfizer patent for pneumonia vaccine

Source: Live Mint India has granted Pfizer a patent for Prevnar 13 pneumonia vaccine, in spite of opposition from the heath group Médecins Sans Frontières (MSF) New Delhi: India has granted US pharmaceutical company Pfizer Inc. a patent for its pneumonia … Continue reading

Posted in Evergreening, Indian Patent Law, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Indian patent for Pfizer’s pneumonia vaccine seen as a blow to aid group

Source: The HinduBusinessLine MUMBAI, AUGUST 22:   The grant of an Indian patent to Pfizer’s Prevenar13, a pneumococcal conjugate vaccine, has raised the hackles of pro-health group MSF who are worried that it will hamper access to the vaccine. “It’s unfair … Continue reading

Posted in Evergreening, Indian Patent Law, Patent, Patent Opposition, Uncategorized, Vaccines | Leave a comment

Draft Pharmaceutical Policy, 2017

Source: All India Drug Action Network (AIDAN) The Department of Pharmaceuticals has circulated a Draft Pharmaceutical Policy, 2017 which can be accessed here. The draft policy identifies the following key objectives: a. Making essential drugs accessible at affordable prices to the … Continue reading

Posted in API, Biologics/Biosimilars, Evergreening, Innovation, IPR, Patent, R&D, Uncategorized | Leave a comment